MedWatch

Hearing aid CEO predicts big rebound after virus year and massive costs shutting down subsidiary

The Covid-19 pandemic and costs relating to shutting down a Chinese subsidiary in 2020 have been costly for Estron, which provides equipment to large hearing aid companies. 2021 will be more positive, predicts the CEO, who estimates that the operating result will more than double.

Estron Managing Director, CEO, Kim Nyborg Carlsen | Photo: Estron / PR

As a developer and manufacturer of hearing equipment for many of the world's largest hearing aid companies, Danish Estron has suffered during this difficult year for the industry, whose primary target group, elderly people, have mostly opted out of visiting their audiologists, thereby not purchasing new hearing aids.

At the end of 2020, Estron Managing Director, CEO, Kim Nyborg Carlsen noted that the company's gross earnings had taken a dive to land at 38 percent.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs